View Cart (0 items)

Pharmaceutical

Glaxo signs deal with Concert on early stage drugs

June 2, 2009
GlaxoSmithKline PLC signed a potential $1 billion deal with U.S. biotech company Concert Pharmaceuticals to access deuterium-containing medicines, a deal that will beef up its pipeline of early stage drugs,
Read More

Rich nations lock in flu vaccine as poor ones fret

May 18, 2009
A scramble among wealthy nations to guard against a swine flu pandemic is raising concerns that billions of people in poorer countries could be left without adequate supplies of
Read More

Elsevier unit failed to disclose journal sponsors

May 11, 2009
Elsevier, the publisher of some of the top medical journals in the world, said their Australian unit contracted with drugmakers to publish what appeared to be medical journals that didn''t
Read More

Group wants boxed warning on constipation drug

May 11, 2009
Consumer advocates are calling on the Food and Drug Administration to add stronger warning labels about risks for pregnant women related to a constipation drug, according to the Associated Press.
Read More

The ten most promising new drugs

May 6, 2009
BusinessWeek reports that Standard & Poor''s RatingsDirect has revealed a compilation of the most promising late-stage drugs due out over the next two years. As the pharmaceutical industry continues to
Read More

Flu a windfall for some drugmakers, shares jump

April 27, 2009
The threat of a pandemic triggered by a new flu strain that has killed more than 100 people in Mexico will provide a windfall for some makers of drugs and
Read More

Glaxo buys Stiefel Laboratories for $2.9 billion

April 21, 2009
According to the Associated Press, British drugmaker GlaxoSmithKline PLC will pay $2.9 billion to buy U.S. dermatology business Stiefel Laboratories Inc. GlaxoSmithKline will also assume $400 million in debt and
Read More

Pfizer offers to boost stake in Indian arm

April 13, 2009
U.S. drug maker Pfizer Inc. has offered to pay about $136 million to boost its stake in its Indian arm Pfizer Ltd, Profile, Research, to 75-percent, according to Reuters. Pfizer
Read More

French drug maker Sanofi to buy Brazil''s Medley

April 13, 2009
French drug maker Sanofi-Aventis SA announced that it is buying Brazilian pharmaceutical company Medley for 1.5 billion reals (euro500 million, $662 million), as reported by the Associated Press. Medley is
Read More

Bristol-Myers, Japanese drugmaker expand deal

April 6, 2009
Drugmaker Bristol-Myers Squibb Co. has struck a deal with a Japanese partner to extend their partnership on one drug by 2 1/2 years and to collaborate on two others, reported
Read More